Trials / Completed
CompletedNCT00544557
Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis
Observational Study Of The Use Of Enbrel (Registered) (Etanercept) In Routine Clinical Practice To Treat Ankylosing Spondylitis (as) Patients: An Effectiveness, Safety, And Health Economic Evaluation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,715 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to provide a holistic assessment of patients receiving etanercept in a real-world setting.
Detailed description
Non-interventional study: subjects to be selected according to the usual clinical practice of their physician
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Etanercept | The patients will be treated in accordance with the requirements of the labeling of etanercept in Germany. The dosage and duration of therapy is to be determined by the physician to meet the patients' individual needs for treatment. |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2007-10-16
- Last updated
- 2015-05-12
- Results posted
- 2015-05-12
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00544557. Inclusion in this directory is not an endorsement.